← Leaderboards
Elizabeth A Maher
Dana-Farber Cancer Institute
$5,123,370
Attributed
$5,123,370
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $520.9K · FY2009–22$1M$750K$500K$250K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$5,123,370 · 6
By mechanism
R01$3,524,009 · 1
RC1$1,000,000 · 1
K08$528,444 · 1
P41$70,917 · 3
Top collaborators
No co-investigators on record.
Most similar at Dana-Farber Cancer Institute
Same institution · by research overlap
- Zoltan P Arany$25,367,590
- Sandy S Chang$11,703,226
- Othon Iliopoulos$11,620,320
- Lynda Chin$27,359,435
- William C Hahn$46,384,528
Others in their field
Top investigators on “Glioma”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$158,144,386
- Todd A Alonzo · University Of Colorado Denver/Hsc Denver$72,436,447
- David Heimbrook · Leidos Biomedical Research, Inc.$56,561,099
- Gregory H Reaman · National Childhood Cancer Foundation$49,046,612
- Melissa L Bondy · Stanford University$36,047,564
- Brad H. Pollock · University Of Florida$28,646,726
Research focus
GliomaGlucoseProductionTumorCellsMetabolismMetabolicCell ProliferationMutationIn VivoMetabolic PathwayGrowthNeoplastic CellResponseGenotypeGene MutationEventAdultMolecularMouse ModelInterestCitric Acid CycleInfusion ProceduresCharacteristics
Grant awards (19)
Understanding the role of IDH in malignant gliomas$377,052
R01 · FY2022 · CA · contact PI
Understanding the role of IDH in malignant gliomas$384,750
R01 · FY2021 · CA · contact PI
Understanding the role of IDH in malignant gliomas$384,750
R01 · FY2020 · CA · contact PI
Understanding the role of IDH in malignant gliomas$373,207
R01 · FY2019 · CA · contact PI
Understanding the role of IDH in malignant gliomas$384,750
R01 · FY2018 · CA · contact PI
Defining the metabolic phenotype of low grade gliomas in vivo$329,925
R01 · FY2016 · CA · contact PI
Defining the metabolic phenotype of low grade gliomas in vivo$329,925
R01 · FY2015 · CA · contact PI
Defining the metabolic phenotype of low grade gliomas in vivo$320,027
R01 · FY2014 · CA · contact PI
Defining the metabolic phenotype of low grade gliomas in vivo$310,130
R01 · FY2013 · CA · contact PI
Defining the metabolic phenotype of low grade gliomas in vivo$329,493
R01 · FY2012 · CA · contact PI
GLIOMA METABOLISM IN PATIENTS IN VIVO$32,163
P41 · FY2011 · RR · contact PI
Genotype and Metabolic Phenotype in Glioblastoma$500,000
RC1 · FY2010 · NS · contact PI
GENOTYPE AND METABOLIC PHENOTYPE IN GLIOBLASTOMA$20,916
P41 · FY2010 · RR · contact PI
Genotype and Metabolic Phenotype in Glioblastoma$500,000
RC1 · FY2009 · NS · contact PI
METABOLISM IN HUMAN GLIOMAS$17,838
P41 · FY2009 · RR · contact PI
GENETIC PATHWAYS TOWARD GLIOMAGENESIS$132,111
K08 · FY2003 · CA
GENETIC PATHWAYS TOWARD GLIOMAGENESIS$132,111
K08 · FY2002 · CA
GENETIC PATHWAYS TOWARD GLIOMAGENESIS$132,111
K08 · FY2001 · CA
GENETIC PATHWAYS TOWARD GLIOMAGENESIS$132,111
K08 · FY2000 · CA